Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02706483 · ClinicalTrials.gov registry record · Phase 3
Long Term Safety Study of Plecanatide
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,272
- Enrollment target
NCT02706483: Completed Phase 3 study, sponsored by Bausch Health Americas.
NCT02706483 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 2,272 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (194% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02706483, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,272 participants
- Enrollment target
Study Summary
Multi-center, open-label, long-term safety study
Primary Outcome
Number of participants with adverse events with evidence to suggest a causal relationship between treatment and study drug.
Interventions
- DRUG Plecanatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,272 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-06 |
| Phase | Phase 3 |
What the finished NCT02706483 record still lists
NCT02706483 is an interventional study that assigns participants to a tested intervention. Its 2,272 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (194% higher).
The record links to 0 conditions, and to 1 intervention - of which Plecanatide is the first listed.
NCT02706483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02706483 about?
NCT02706483 is a clinical study titled "Long Term Safety Study of Plecanatide". Multi-center, open-label, long-term safety study
What is the current status of trial NCT02706483?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,272 participants. The study started on 2016-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02706483?
The interventions under investigation include: Plecanatide (DRUG).
Who is sponsoring clinical trial NCT02706483?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02706483's enrollment target sits among peer trials
2,272 94th of 2000 higher than 1,907 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia